|
Market Closed -
Nasdaq
23:00:00 20/08/2026 +03
|
5-day change | 1st Jan Change | ||
| 37.78 USD | -3.23% |
|
-1.15% | +5.30% |
| 08-03 | Indivior Pharmaceuticals, Inc. Enters into Senior Secured Term Loan Facility | CI |
| 08-03 | Indivior Pharmaceuticals, Inc. Proposes Special Cash Dividend | CI |
| Market Cap | 4.46B 3.82B 3.57B 3.27B 6.15B 427B 6.27B 42.29B 16.49B 214B 16.76B 16.39B 708B | P/E 2026 * |
10.2x | P/E 2027 * | 9.2x |
|---|---|---|---|---|---|
| Enterprise Value | 4.45B 3.81B 3.56B 3.26B 6.13B 426B 6.25B 42.17B 16.44B 213B 16.71B 16.35B 706B | EV / Sales 2026 * |
3.34x | EV / Sales 2027 * | 2.78x |
| Free-Float |
97.98% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Indivior Pharmaceuticals, Inc.
| 1 day | -3.23% | ||
| 1 week | -1.15% | ||
| Current month | -5.57% | ||
| 1 month | -3.43% | ||
| 3 months | +0.51% | ||
| 6 months | +11.48% | ||
| Current year | +5.30% |
| 1 week | 37.64 | 40 | |
| 1 month | 35.76 | 41.65 | |
| Current year | 27.68 | 42.81 | |
| 1 year | 22.22 | 42.81 | |
| 3 years | 7.33 | 42.81 | |
| 5 years | 7.33 | 42.81 | |
| 10 years | 1.75 | 42.81 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 8/5/26 A | Buy | Controller/Auditor | 1,500 | 0.0012% | ||
| 7/10/26 A | Sell | Chief Scientific Officer | -18,586 | 0.0152% | ||
| 5/13/26 A | Free | Director | 6,518 | 0.0053% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -3.23% | -1.15% | +56.44% | +70.56% | 4.61B | ||
| -2.81% | +2.93% | +76.40% | +127.73% | 1,141B | ||
| -2.21% | +2.02% | +49.50% | +55.01% | 659B | ||
| -1.56% | +4.39% | +25.19% | +74.39% | 470B | ||
| +1.20% | +2.62% | +41.69% | +45.78% | 366B | ||
| -0.61% | +2.10% | +23.43% | +41.34% | 302B | ||
| +0.32% | +3.25% | +0.94% | +13.42% | 254B | ||
| -1.95% | +3.80% | +46.31% | +65.66% | 239B | ||
| -1.10% | -0.70% | -14.31% | -52.66% | 207B | ||
| -2.82% | +3.84% | +20.81% | +89.04% | 183B | ||
| Average | -1.48% | +2.47% | +32.64% | +53.03% | 382.56B | |
| Weighted average by Cap. | -1.64% | +3.11% | +43.50% | +70.86% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.33B 1.14B 1.06B 976M 1.83B 127B 1.87B 12.62B 4.92B 63.87B 5B 4.89B 211B | 1.4B 1.2B 1.12B 1.03B 1.93B 134B 1.97B 13.26B 5.17B 67.11B 5.25B 5.14B 222B |
| Net income | 474M 406M 379M 348M 653M 45.38B 666M 4.49B 1.75B 22.74B 1.78B 1.74B 75.29B | 530M 454M 423M 388M 730M 50.71B 744M 5.02B 1.96B 25.41B 1.99B 1.95B 84.14B |
| Net Debt | -12.5M -10.7M -9.99M -9.16M -17.22M -1.2B -17.56M -118M -46.18M -599M -46.94M -45.91M -1.98B | -570M -488M -455M -418M -785M -54.54B -801M -5.4B -2.11B -27.33B -2.14B -2.09B -90.49B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 20/08/26 | $37.78 | -3.23% | 1,442,317 |
| 19/08/26 | $39.04 | -0.99% | 2,476,877 |
| 18/08/26 | $39.43 | +0.90% | 2,338,564 |
| 17/08/26 | $39.08 | +0.18% | 2,018,200 |
| 14/08/26 | $39.01 | +2.07% | 988,395 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.

Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- INDV Stock
Select your edition
All financial news and data tailored to specific country editions

















